INTEGRATED BIOPHARMA INC
Ticker: 1016504
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 10.11-10.4% | 11.28-11.1% | 12.69-9.0% | 13.95+10.6% | 12.61-7.4% | 13.62+3.6% | 13.15+14.2% | 11.51 |
| Total Income | 10.11-10.4% | 11.28-11.1% | 12.69-9.0% | 13.95+10.6% | 12.61-7.4% | 13.62+3.6% | 13.15+14.2% | 11.51 |
| EXPENSES | ||||||||
| Expenditure | 11.19-8.2% | 12.19-2.7% | 12.53-5.1% | 13.21+6.4% | 12.41-5.5% | 13.13+2.7% | 12.79+6.9% | 11.96 |
| Tax | -0.20-81.8% | -0.11-257.1% | 0.07-58.8% | 0.17+142.9% | 0.07-72.0% | 0.25+257.1% | 0.07+200.0% | -0.07 |
| PROFIT | ||||||||
| PBT | -1.04-19.5% | -0.87-535.0% | 0.20-74.4% | 0.78+310.5% | 0.19-62.0% | 0.50+42.9% | 0.35+177.8% | -0.45 |
| Net Profit | -0.84-10.5% | -0.76-733.3% | 0.12-80.3% | 0.61+408.3% | 0.12-53.8% | 0.26-10.3% | 0.29+176.3% | -0.38 |
| KEY METRICS | ||||||||
| OPM % | -10.73%-2.63pp | -8.10%-9.39pp | 1.28%-4.01pp | 5.30%+3.70pp | 1.60%-2.00pp | 3.60%+0.90pp | 2.70%+6.63pp | -3.93% |
| NPM % | -8.28%-1.53pp | -6.75%-7.72pp | 0.97%-3.41pp | 4.38%+3.46pp | 0.92%-0.98pp | 1.90%-0.27pp | 2.17%+5.49pp | -3.32% |
| EPS | -0.03+0.0% | -0.03 | 0.00-100.0% | 0.02 | 0.00-100.0% | 0.01+0.0% | 0.01+200.0% | -0.01 |
Corporate Events
No corporate events found.